查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1593447

射頻消融治療設備市場規模、佔有率、成長分析（按類型、按組件類型、按應用、按地區）- 產業預測，2024-2031年

Radiofrequency Ablation Devices Market Size, Share, Growth Analysis, By Type, By Component Type, By Application, By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 200 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年，射頻消融（RFA）設備的全球市場規模為43.4億美元，預計在預測期內從2023年的48.5億美元成長到2031年的116.6億美元，年複合成長率（2024-2031年）為 11.6%。

由於慢性病盛行率的上升、對微創手術選擇的日益偏好以及顯著的技術進步，射頻消融治療設備市場經歷強勁成長。隨著醫療保健系統優先考慮門診手術並解決日益成長的癌症負擔，對這些醫療設備的需求加速成長。然而，射頻消融設備的高成本等挑戰阻礙了其採用，特別是在中等收入和開發中國家。此外，這些地區缺乏熟練的專業人員，這阻礙了市場的擴張。儘管存在這些障礙，市場仍提供了巨大的機會，特別是透過快速發展的地區和 RFA 技術的持續創新。成像系統整合和電極設計改進等市場開拓將提高手術的有效性和安全性，導致市場持續成長。總體而言，儘管存在挑戰，但在不斷成長的醫療需求和技術進步的支持下，射頻消融治療設備市場的未來看起來充滿希望。

目錄

介紹

  • 研究目的
  • 定義
  • 市場範圍

調查方法

  • 資訊採購
  • 二級資料來源和一級資料來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況展望
  • 供需趨勢分析
  • 依細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 課題
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 價值鏈分析
  • 技術分析
  • 專利分析
  • 價格分析
  • 案例研究分析
  • 監管分析
  • PESTEL分析
  • 客戶購買標準分析

射頻消融治療設備市場：依類型

  • 市場概況
  • 單極射頻消融術
  • 雙極射頻射頻消融術

射頻消融治療設備市場：依組件類型

  • 市場概況
  • 免洗設備
  • 資本設備
  • 可重複使用的設備

射頻消融治療設備市場：依應用分類

  • 市場概況
  • 腫瘤外科
  • 心臟病學和心率管理
  • 美容
  • 婦科
  • 疼痛管理

射頻消融治療設備市場：依最終用途分類

  • 市場概況
  • 醫院
  • 門診手術中心
  • 研究室

射頻消融治療設備市場：依地區

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲（MEA）
    • 海灣合作理事會國家
    • 南非
    • 其他中東、非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位（2023年）
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率（2023年）

主要企業簡介

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Johnson & Johnson
  • Stryker Corporation
  • Smith & Nephew plc
  • Olympus Corporation
  • Hologic, Inc.
  • Merit Medical Systems, Inc.
  • AngioDynamics, Inc.
  • CryoLife, Inc.（Artivion, Inc.）
  • AtriCure, Inc.
  • ELIAS Medical
  • Eppendorf AG
  • Sientra, Inc.
  • Neotract, Inc.
  • Biotronik SE & Co. KG
  • Ablative Solutions, Inc.
簡介目錄
Product Code: SQMIG35A2903

Global Radiofrequency Ablation Devices Market size was valued at USD 4.34 Billion in 2022 and is poised to grow from USD 4.85 Billion in 2023 to USD 11.66 Billion by 2031, growing at a CAGR of 11.6% in the forecast period (2024-2031).

The radiofrequency ablation devices market is experiencing robust growth driven by the rising prevalence of chronic conditions, an increasing preference for minimally invasive surgical options, and significant technological advancements. As healthcare systems prioritize outpatient procedures and address the growing cancer burden, the demand for these medical devices is accelerating. However, challenges such as the high costs associated with radiofrequency ablation devices pose barriers to adoption, particularly in middle-income and developing nations. Additionally, a shortage of skilled professionals in these regions further hampers market expansion. Despite these obstacles, the market presents substantial opportunities, particularly in rapidly developing areas and through ongoing innovations in RFA technologies. Developments such as the integration of imaging systems and improvements in electrode design are set to enhance procedural efficacy and safety, positioning the market for continued growth. Overall, while challenges exist, the future of the radiofrequency ablation devices market appears promising, supported by rising healthcare needs and technological progress.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radiofrequency Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radiofrequency Ablation Devices Market Segmental Analysis

Global Radiofrequency Ablation Devices Market is segmented by Type, Component Type, Application, End Use, and region. Based on Type, the market is segmented into Unipolar Radiofrequency Ablation, and Bipolar Radiofrequency Ablation. Based on Component Type, the market is segmented into Disposable equipment, Capital equipment, and Reusable equipment. Based on Application, the market is segmented into Surgical oncology, Cardiology & cardiac rhythm management, Cosmetology, Gynecology, and Pain management. Based on Application, the market is segmented into Hospital, Ambulatory Surgery Centers, and Research laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Radiofrequency Ablation Devices Market

The global radiofrequency ablation (RFA) devices market is being driven by the rising demand for minimally invasive procedures, which provide numerous advantages over traditional surgical methods, such as reduced infection risks, shorter recovery periods, and decreased postoperative discomfort. Additionally, the expanding aging population, which is more susceptible to chronic diseases and tumors requiring RFA treatment, is further propelling market growth. As healthcare systems increasingly prioritize patient-centric and cost-effective treatment options, the inclination towards RFA procedures continues to surge, effectively positioning the market for significant expansion in response to evolving medical needs and demographic trends.

Restraints in the Global Radiofrequency Ablation Devices Market

The global radiofrequency ablation (RFA) devices market faces significant restraints due to concerns over potential complications associated with the procedure, including bleeding, damage to adjacent tissues, and infections. These risks can lead to hesitation among both healthcare providers and patients, discouraging the adoption of RFA as a preferred treatment option. Moreover, the market is further constrained by a shortage of skilled professionals in certain regions, which limits the effective utilization of RFA technologies. This dual challenge of perceived risks and insufficient expertise could hinder market growth and slow the acceptance of radiofrequency ablation as a mainstream therapeutic modality.

Market Trends of the Global Radiofrequency Ablation Devices Market

The Global Radiofrequency Ablation Devices market is currently witnessing a significant trend towards the adoption of advanced technologies such as Pulsed Field Ablation (PFA). This innovative approach leverages large electrodes to reduce current density, enabling non-thermal ablation that primarily targets myocardial tissue with minimal impact on surrounding structures like nerves and the esophagus. Recent studies highlighting PFA's efficacy have spurred interest from healthcare professionals and researchers alike, suggesting a shift in treatment paradigms for conditions like cardiac arrhythmias. As a result, the demand for radiofrequency ablation devices incorporating PFA technology is expected to grow, driving market expansion and innovation.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Value Chain Analysis
  • Technology Analysis
  • Patent Analysis
  • Pricing Analysis
  • Case Study Analysis
  • Regulatory Analysis
  • PESTEL Analysis
  • Customer Buying Criteria Analysis

Radiofrequency Ablation Devices Market, By Type

  • Market Overview
  • Unipolar Radiofrequency Ablation
  • Bipolar Radiofrequency Ablation

Radiofrequency Ablation Devices Market, By Component Type

  • Market Overview
  • Disposable equipment
  • Capital equipment
  • Reusable equipment

Radiofrequency Ablation Devices Market, By Application

  • Market Overview
  • Surgical oncology
  • Cardiology & cardiac rhythm management
  • Cosmetology
  • Gynecology
  • Pain management

Radiofrequency Ablation Devices Market, By End Use

  • Market Overview
  • Hospital
  • Ambulatory Surgery Centers
  • Research Laboratories

Radiofrequency Ablation Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CryoLife, Inc. (Artivion, Inc.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AtriCure, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ELIAS Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eppendorf AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sientra, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neotract, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ablative Solutions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments